共 170 条
[41]
El-Ossaily Y.A., 2024, Curr. Chem. Lett., V13, P127, DOI [10.5267/j.ccl.2023.8.003, DOI 10.5267/J.CCL.2023.8.003]
[43]
New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study
[J].
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY,
2023, 38 (01)
[44]
New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies
[J].
BIOORGANIC CHEMISTRY,
2020, 98
[47]
A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents
[J].
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS,
2022, 5
[49]
He SP, 2018, J MED CHEM, V61, P7245, DOI [10.1021/acs.jmedchem.8b0064, 10.1021/acs.jmedchem.8b00664]
[50]
Prescribed drugs containing nitrogen heterocycles: an overview
[J].
RSC ADVANCES,
2020, 10 (72)
:44247-44311